122 related articles for article (PubMed ID: 2396944)
21. [The effect of mammographic screening on tumor size, axillary node status and the degree of histologic anaplasia].
Garami Z; Benkó K; Kósa C; Fülöp B; Lukács G
Magy Seb; 2006 Oct; 59(5):383-7. PubMed ID: 17201347
[TBL] [Abstract][Full Text] [Related]
22. Preliminary results of the Nottingham breast self-examination education programme.
Dowle CS; Mitchell A; Elston CW; Roebuck EJ; Hinton CP; Holliday H; Blamey RW
Br J Surg; 1987 Mar; 74(3):217-9. PubMed ID: 3567517
[TBL] [Abstract][Full Text] [Related]
23. Clinical and self breast examination remain important in the era of modern screening.
Ma I; Dueck A; Gray R; Wasif N; Giurescu M; Lorans R; Pizzitola V; Pockaj B
Ann Surg Oncol; 2012 May; 19(5):1484-90. PubMed ID: 22160521
[TBL] [Abstract][Full Text] [Related]
24. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.
Miller AB; To T; Baines CJ; Wall C
J Natl Cancer Inst; 2000 Sep; 92(18):1490-9. PubMed ID: 10995804
[TBL] [Abstract][Full Text] [Related]
25. Palpable presentation of breast cancer persists in the era of screening mammography.
Mathis KL; Hoskin TL; Boughey JC; Crownhart BS; Brandt KR; Vachon CM; Grant CS; Degnim AC
J Am Coll Surg; 2010 Mar; 210(3):314-8. PubMed ID: 20193894
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer and earlier detection efforts. Realized and unrealized impact on stage.
Farwell MF; Foster RS; Costanza MC
Arch Surg; 1993 May; 128(5):510-3; discussion 513-4. PubMed ID: 8489384
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer screening methods: a review of the evidence.
Vahabi M
Health Care Women Int; 2003 Nov; 24(9):773-93. PubMed ID: 14742116
[TBL] [Abstract][Full Text] [Related]
28. Nonpalpable breast cancer in women aged 40-49 years: a surgeon's view of benefits from screening mammography.
Chang HR; Cole B; Bland KI
J Natl Cancer Inst Monogr; 1997; (22):145-9. PubMed ID: 9709291
[TBL] [Abstract][Full Text] [Related]
29. Breast-cancer mortality in screened versus unscreened women: Long-term results from a population-based study in Queensland, Australia.
Dunn N; Youl P; Moore J; Harden H; Walpole E; Evans E; Taylor K; Philpot S; Furnival C
J Med Screen; 2021 Jun; 28(2):193-199. PubMed ID: 32842857
[TBL] [Abstract][Full Text] [Related]
30. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women.
Wang WV; Tan SM; Chow WL
Asian Pac J Cancer Prev; 2011; 12(10):2735-40. PubMed ID: 22320984
[TBL] [Abstract][Full Text] [Related]
31. Mammography in symptomatic and asymptomatic patients.
Stomper PC; Gelman RS
Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
[TBL] [Abstract][Full Text] [Related]
32. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials.
de Koning HJ; Boer R; Warmerdam PG; Beemsterboer PM; van der Maas PJ
J Natl Cancer Inst; 1995 Aug; 87(16):1217-23. PubMed ID: 7563167
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer screening.
Jatoi I
Am J Surg; 1999 Jun; 177(6):518-24. PubMed ID: 10414706
[TBL] [Abstract][Full Text] [Related]
34. Method of tumor detection influences disease-free survival of women with breast carcinoma.
Senie RT; Lesser M; Kinne DW; Rosen PP
Cancer; 1994 Mar; 73(6):1666-72. PubMed ID: 8156494
[TBL] [Abstract][Full Text] [Related]
35. The detection and diagnosis of early, occult and minimal breast cancer.
Hickey RC; Gallager HS; Dodd GD; Samuels BI; Paulus DD; Moore DL
Adv Surg; 1976; 10():287-312. PubMed ID: 185891
[TBL] [Abstract][Full Text] [Related]
36. Tubular breast cancer experience at Washington University: a review of the literature.
Holland DW; Boucher LD; Mortimer JE
Clin Breast Cancer; 2001 Oct; 2(3):210-4. PubMed ID: 11899414
[TBL] [Abstract][Full Text] [Related]
37. Mammographic screening of women aged 40 to 49 years. Is it justified?
Feig SA
Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
[TBL] [Abstract][Full Text] [Related]
38. Mammographic screening and disease presentation of breast cancer patients who die of disease.
Spencer DB; Potter JE; Chung MA; Fulton J; Hebert W; Cady B
Breast J; 2004; 10(4):298-303. PubMed ID: 15239787
[TBL] [Abstract][Full Text] [Related]
39. Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
Taplin SH; Ichikawa L; Yood MU; Manos MM; Geiger AM; Weinmann S; Gilbert J; Mouchawar J; Leyden WA; Altaras R; Beverly RK; Casso D; Westbrook EO; Bischoff K; Zapka JG; Barlow WE
J Natl Cancer Inst; 2004 Oct; 96(20):1518-27. PubMed ID: 15494602
[TBL] [Abstract][Full Text] [Related]
40. Discovery method and stage of breast cancer in two different patient populations.
Tigges S; Monticciolo DL; Kessler L
South Med J; 1995 Nov; 88(11):1114-7. PubMed ID: 7481980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
